Together with our trusted practitioners, we aim to achieve the best possible results and the highest quality of life for our patients
Australia’s first ISO9001:2015 Compounding Pharmacy. We have a quality management system for the provision of customised, tailor made medicines recognised throughout the world. Compounding Industry Landmark We are proud to announce that Kingsway Compounding is now officially an ISO9001 Certified Quality Approved Compounder.
Naltrexone itself is a TGA approved medication (brand name Revia), which has been used since the 1970’s as an opiate antagonist for treating opiate drug and alcohol addiction. At regular dosing, to treat addiction, usually 50-150mg a day, it has shown to block the euphoric response to opiate drugs such as heroin, morphine and alcohol.…
Sometimes chemicals in our environment could do more harm than good. Studies find that some of it have been linked to obesity due to low-level hormonal impacts. These chemicals are referred to as “obesogens” and they contribute to the obesity epidemic by disrupting how our bodies create and store fat. The good news is there…
At Kingsway Compounding we namely work with Integrative Practitioners or those practitioners that subscribe to Integrative Medicine.
“The term Integrative Medicine (IM) refers to the blending of conventional and natural/complementary medicines and/or therapies along with lifestyle interventions and a holistic approach – taking into account the physical, psychological, social and spiritual wellbeing of the person – with the aim of using the most appropriate, safe and evidence-based modality(ies) available.”
Source: AIMA joint working party/RACGP : ‘Best Practice’ document.
“Integrative Medicine is the practice of medicine that reaffirms the importance of the relationship between practitioner and patient, focuses on the whole person, is informed by evidence, and makes use of all appropriate therapeutic approaches, health care professionals and disciplines to achieve optimal health and healing.”
Source: Developed and Adopted by The Consortium, May 2004 Edited May 2009 and November 2009.